Applications of Biomaterials in Plastic Surgery

Clinics in Plastic Surgery

Volumn 39, Issue 4, 2012, Pages 359-376

  Kim, Jeff J ^a   Evans, Gregory R D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acellular dermal matrix; Biomaterials; Drug delivery; Wound healing

Indexed keywords

ALGINIC ACID; BIOBRANE; BIOMATERIAL; CALCIUM PHOSPHATE; CARBOXYMETHYLCELLULOSE; CHONDROITIN 6 SULFATE; COLLAGEN; ELASTOMER; FIBRIN GLUE; GELATIN; HEPARIN; HYALURONIC ACID; HYDROXYAPATITE; MARLEX; METHACRYLIC ACID METHYL ESTER; MICROSPHERE; NYLON; PECTIN; POLITEF; POLY(METHYL METHACRYLATE); POLYCAPROLACTONE; POLYETHYLENE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT GROWTH FACTOR; SILICONE; SILVER;

ACELLULAR DERMAL MATRIX; BIOENGINEERING; BIOPROSTHESIS; BREAST RECONSTRUCTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED DRUG RELEASE; CRANIOFACIAL SURGERY; DRUG DELIVERY SYSTEM; EPIDERMIS; FOAM DRESSING; FREEZE DRYING; HUMAN; HYDROCOLLOID DRESSING; HYDROGEL; KERATINOCYTE; NERVE REGENERATION; PERIPHERAL NEUROPATHY; PLASTIC SURGERY; REVIEW; SKIN FIBROBLAST; TISSUE ENGINEERING; TREATMENT INDICATION; WOUND DRESSING; WOUND HEALING;

ABDOMINAL WALL; ACELLULAR DERMIS; ANTI-BACTERIAL AGENTS; BANDAGES; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; BREAST; CALCIUM PHOSPHATES; COLLAGEN; DRUG DELIVERY SYSTEMS; GROWTH SUBSTANCES; HUMANS; HYALURONIC ACID; PERIPHERAL NERVE INJURIES; POLYMERS; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; SURGERY, PLASTIC; SURGICAL WOUND INFECTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VISCOSUPPLEMENTS; WOUND HEALING;

EID: 84867129614     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2012.07.007     Document Type: Review

References (73)

1. Centers for Medicare & Medicaid Services. Guidance to surveyors for long term care facilities. Available at: Accessed April 28, 2012. http://www.cms.hhs.gov.
2. Fan K., Tang J., Escandon J., et al. State of the art in topical wound-healing products. Plast Reconstr Surg 2011, 127(Suppl):44S-59S. Available at:, Accessed March 19, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21200273.
3. Groeber F., Holeiter M., Hampel M., et al. Skin tissue engineering-in vivo and in vitro applications. Adv Drug Deliv Rev 2011, 63(4-5):352-366. Available at:, Accessed March 10, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21241756.
4. Lazic T., Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg 2011, 127(Suppl):75S-90S. Available at:, Accessed March 19, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21200276.
5. Atiyeh B.S., Gunn S.W., Hayek S.N. State of the art in burn treatment. World J Surg 2005, 29(2):131-148. Available at:, Accessed March 16, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15654666.
6. Atiyeh B.S., Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007, 33(4):405-413. Available at:, Accessed March 7, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17400392.
7. Horch R.E., Kopp J., Kneser U., et al. Tissue engineering of cultured skin substitutes. J Cell Mol Med 2005, 9(3):592-608. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16202208.
8. Ovington L. The art and science of wound dressings in the twenty-first century. Wound healing 2005, 1-7. Taylor & Francis Group, Boca Raton (FL). A. Falabella, R. Kirsner (Eds.).
9. Cuzzell J. Choosing a wound dressing. Geriatr Nurs 1997, 18(6):260-265. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/9469058.
10. Jones V., Grey J.E., Harding K.G. Wound dressings. BMJ 2006, 332(7544):777-780. Available at:, Accessed March 19, 2012. http://www.pubmedcentral.nih.gov/articlerender.fcgi%3Fartid=1420733%26tool=pmcentrez%26rendertype=abstract.
11. Hess C.T., Kirsner R.S. Orchestrating wound healing: assessing and preparing the wound bed. Adv Skin Wound Care 2003, 16(5):246-257. [quiz: 258-9]. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/14581817.
12. Hess C. Wound care 2005, Lippincott Williams & Wilkins, Philadelphia. 5th edition.
13. Vermeulen H., van Hattem J.M., Storm-Versloot M.N., et al. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007, (1). CD005486. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17253557.
14. Jørgensen B., Price P., Andersen K.E., et al. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J 2005, 2(1):64-73. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16722854.
15. Edwards J.V., Bopp A.F., Batiste S., et al. Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: in vitro kinetics and inhibitor release. Wound Repair Regen 1999, 7(2):106-118. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/10231512.
16. Broder K.W., Cohen S.R. An overview of permanent and semipermanent fillers. Plast Reconstr Surg 2006, 118(Suppl 3):7S-14S. Available at:, Accessed April 5, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16936539.
17. Eppley B.L., Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 2006, 118(4):98e-106e. Available at:, Accessed March 8, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16980841.
18. Maloney B.P., Murphy B.A., Cole H.P. Cymetra. Facial Plast Surg 2004, 20(2):129-134. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15643579.
19. André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 2004, 18(4):422-425. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15196154.
20. Narins R.S., Brandt F., Leyden J., et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003, 29(6):588-595. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/12786700.
21. Manna F., Dentini M., Desideri P., et al. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and Restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol 1999, 13(3):183-192. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/10642054.
22. Kanchwala S.K., Holloway L., Bucky L.P. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg 2005, 55(1):30-35. [discussion: 35]. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15985788.
23. Kane M.A.C. Treatment of tear trough deformity and lower lid bowing with injectable hyaluronic acid. Aesthetic Plast Surg 2005, 29(5):363-367. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16151656.
24. Lowe N.J., Maxwell C.A., Lowe P., et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001, 45(6):930-933. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/11712042.
25. Lemperle G., Morhenn V., Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003, 27(5):354-366. [discussion: 367]. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/14648064.
26. Friedman P.M., Mafong E.A., Kauvar A.N., et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002, 28(6):491-494. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/12081677.
27. Monheit G.D. Hylaform: a new hyaluronic acid filler. Facial Plast Surg 2004, 20(2):153-155. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15643583.
28. Mayer R., Lightfoot M., Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 2001, 57(3):434-438. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/11248613.
29. Comite S.L., Liu J.F., Balasubramanian S., et al. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse). Dermatol Online J 2004, 10(2):2. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15530292.
30. Vleggaar D., Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drug Dermatol 2004, 3(5):542-547. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15552606.
31. Humble G., Mest D. Soft tissue augmentation using sculptra. Facial Plast Surg 2004, 20(2):157-163. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15643584.
32. Cohen S.R., Holmes R.E. Artecoll: a long-lasting injectable wrinkle filler material: Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004, 114(4):964-976. [discussion: 977-9]. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15468406.
33. Bogdan Allemann I., Baumann L. Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging 2008, 3(4):629. Available at:, Accessed May 8, 2012. mailto:/pmc/articles/PMC2682392/%3Freport=abstract.
34. Silverman R.P. Acellular dermal matrix in abdominal wall reconstruction. Aesthet Surg J 2011, 31(Suppl 7):24S-29S. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21908821.
35. Fosnot J., Kovach S.J., Serletti J.M. Acellular dermal matrix: general principles for the plastic surgeon. Aesthet Surg J 2011, 31(Suppl 7):5S-12S. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21908819.
36. Butler C.E. The role of bioprosthetics in abdominal wall reconstruction. Clin Plast Surg 2006, 33(2):199-211. v-vi. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16638463.
37. Butler C.E., Langstein H.N., Kronowitz S.J. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast Reconstr Surg 2005, 116(5):1263-1275. [discussion: 1276-7]. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16217466.
38. Gamboa-Bobadilla G.M. Implant breast reconstruction using acellular dermal matrix. Ann Plast Surg 2006, 56(1):22-25. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16374090.
39. Zienowicz R.J., Karacaoglu E. Implant-based breast reconstruction with allograft. Plast Reconstr Surg 2007, 120(2):373-381. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17632337.
40. Nahabedian M.Y., Spear S.L. Acellular dermal matrix for secondary procedures following prosthetic breast reconstruction. Aesthet Surg J 2011, 31(Suppl 7):38S-50S. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21908823.
41. Spear S.L. Discussion. Acellular dermis-assisted prosthetic breast reconstruction versus complete submuscular coverage: a head-to-head comparison of outcomes. Plast Reconstr Surg 2009, 124(6):1741-1742. Available at:, Accessed March 19, 2012. http://www.ncbi.nlm.nih.gov/pubmed/19952628.
42. Spear S.L., Howard M.A., Boehmler J.H., et al. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 2004, 113(6):1634-1644. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15114123.
43. Stump A., Holton L.H., Connor J., et al. The use of acellular dermal matrix to prevent capsule formation around implants in a primate model. Plast Reconstr Surg 2009, 124(1):82-91. Available at:, Accessed March 19, 2012. http://www.ncbi.nlm.nih.gov/pubmed/19568048.
44. Komorowska-Timek E., Oberg K.C., Timek T.A., et al. The effect of AlloDerm envelopes on periprosthetic capsule formation with and without radiation. Plast Reconstr Surg 2009, 123(3):807-816. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/19319043.
45. Basu C.B., Leong M., Hicks M.J. Acellular cadaveric dermis decreases the inflammatory response in capsule formation in reconstructive breast surgery. Plast Reconstr Surg 2010, 126(6):1842-1847. Available at:, Accessed March 25, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21124125.
46. Sbitany H., Langstein H.N. Acellular dermal matrix in primary breast reconstruction. Aesthet Surg J 2011, 31(Suppl 7):30S-37S. Available at:, Accessed April 28, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21908822.
47. Brown R.H., Izaddoost S., Bullocks J.M. Preventing the " bottoming out" and " star-gazing" phenomena in inferior pedicle breast reduction with an acellular dermal matrix internal brassiere. Aesthetic Plast Surg 2010, 34(6):760-767. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/20602099.
48. Spear S.L., Seruya M., Clemens M.W., et al. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Reconstr Surg 2011, 127(3):1047-1058. Available at:, Accessed March 3, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21088648.
49. Maxwell G.P., Gabriel A. Use of the acellular dermal matrix in revisionary aesthetic breast surgery. Aesthet Surg J 2009, 29(6):485-493. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/19944993.
50. Hartzell T.L., Taghinia A.H., Chang J., et al. The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: results and costs. Plast Reconstr Surg 2010, 126(5):1711-1720. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/21042128.
51. Cheng A., Saint-Cyr M. Comparison of different ADM materials in breast surgery. Clin Plast Surg 2012, 39(2):167-175. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22482358.
52. Strauch B. Use of nerve conduits in peripheral nerve repair. Hand Clin 2000, 16(1):123-130. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/10696581.
53. Meek M.F., Coert J.H. US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Ann Plast Surg 2008, 60(1):110-116. Available at:, Accessed March 8, 2012. http://www.ncbi.nlm.nih.gov/pubmed/18281807.
54. Meek M.F., Coert J.H. Clinical use of nerve conduits in peripheral-nerve repair: review of the literature. J Reconstr Microsurg 2002, 18(2):97-109. Available at:, Accessed April 25, 2012. http://www.ncbi.nlm.nih.gov/pubmed/11823940.
55. Kretlow J.D., Young S., Klouda L., et al. Injectable Biomaterials for Regenerating Complex Craniofacial Tissues. NIH Public Access 2009, 21(5):3368-3393.
56. Neovius E., Engstrand T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J Plast Reconstr Aesthet Surg 2010, 63(10):1615-1623. Available at:, Accessed April 16, 2012. http://www.ncbi.nlm.nih.gov/pubmed/19577527.
57. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002, (395):81-98. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/11937868.
58. Spivak J.M., Hasharoni A. Use of hydroxyapatite in spine surgery. Eur Spine J 2001, 10(Suppl 2):S197-S204. Available at:, Accessed March 9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/11716019.
59. Oner F.C., Dhert W.J., Verlaan J.J. Less invasive anterior column reconstruction in thoracolumbar fractures. Injury 2005, 36(Suppl 2):B82-B89. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15993121.
60. Friedman C.D., Costantino P.D., Takagi S., et al. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 1998, 43(4):428-432. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/9855201.
61. Cunningham L.L. The use of calcium phosphate cements in the maxillofacial region. J Long Term Eff Med Implants 2005, 15(6):609-615. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16393129.
62. Sanger C., Soto A., Mussa F., et al. Maximizing results in craniofacial surgery with bioresorbable fixation devices. J Craniofac Surg 2007, 18(4):926-930. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17667688.
63. Fedorowicz Z., Nasser M., Newton J.T., et al. Cochrane database of systematic reviews 1996, John Wiley & Sons, Ltd, Chichester (United Kingdom), CD006204. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17443617.
64. Bell R.B., Kindsfater C.S. The use of biodegradable plates and screws to stabilize facial fractures. J Oral Maxillofac Surg 2006, 64(1):31-39. Available at:, Accessed April 18, 2012. http://www.ncbi.nlm.nih.gov/pubmed/16360854.
65. Laughlin R.M., Block M.S., Wilk R., et al. Resorbable plates for the fixation of mandibular fractures: a prospective study. J Oral Maxillofac Surg 2007, 65(1):89-96. Available at:, Accessed March 9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17174770.
66. Quatela V.C., Chow J. Synthetic facial implants. Facial Plast Surg Clin North Am 2008, 16(1):1-10. v. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/18063244.
67. Yaremchuk M.J. Facial skeletal reconstruction using porous polyethylene implants. Plast Reconstr Surg 2003, 111(6):1818-1827. Available at:, Accessed April 5, 2012. http://www.ncbi.nlm.nih.gov/pubmed/12711941.
68. Moreira-Gonzalez A., Jackson I.T., Miyawaki T., et al. Clinical outcome in cranioplasty: critical review in long-term follow-up. J Craniofac Surg 2003, 14(2):144-153. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/12621283.
69. Santin M., Motta A., Borzachiello A., et al. Effect of PMMA cement radical polymerisation on the inflammatory response. J Mater Sci Mater Med 2004, 15(11):1175-1180. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/15880924.
70. Herford A.S., Boyne P.J., Williams R.P. Clinical applications of rhBMP-2 in maxillofacial surgery. J Calif Dent Assoc 2007, 35(5):335-341. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/17822159.
71. Mikos A.G., Herring S.W., Ochareon P., et al. Engineering complex tissues. Tissue Eng 2006, 12(12):3307-3339. Available at:, Accessed April 28, 2012. http://www.pubmedcentral.nih.gov/articlerender.fcgi%3Fartid=2821210%26tool=pmcentrez%26rendertype=abstract.
72. Willerth S.M., Sakiyama-Elbert S.E. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007, 59(4-5):325-338. Available at:, Accessed March 10, 2012. http://www.pubmedcentral.nih.gov/articlerender.fcgi%3Fartid=1976339%26tool=pmcentrez%26rendertype=abstract.
73. Mahoney M.J., Saltzman W.M. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J Pharm Sci 1996, 85(12):1276-1281. Available at:, Accessed April 30, 2012. http://www.ncbi.nlm.nih.gov/pubmed/8961138.